Abstract
Herbal medicinal plants have been used for centuries in traditional medicine, and it is interesting to see how modern research has identified the active compounds responsible for their therapeutic effects. The green synthesis of silver nanoparticles using herbal medicinal plants, such as Swertia chirata, is particularly noteworthy due to its antimicrobial properties. In the current study, the Swertia chirata plant was collected for the first time from the region of Murree, Punjab, Pakistan. After collection, extracts were prepared in different solvents (ethanol, methanol, chloroform, and distilled water), and silver nanoparticles were synthesized by reducing silver nitrate (AgNO3). The UV–visible spectrophotometer, SEM, and EDX were used to characterize the synthesized nanoparticles in terms of their size and shape. The phytochemical analysis of crude extract was performed to determine the presence of different kinds of phytochemicals. The antibacterial activity of plant extracts and the silver nanoparticles were then assessed using the agar well diffusion method against various pathogenic bacteria. The results showed that the plant contains several phytochemicals with remarkable antioxidant potential. The antibacterial analysis revealed that silver nanoparticles and the plant extracts exhibited a significant zone of inhibition against human pathogenic bacteria (Escherichia coli, S. capitis, B. subtilis, and Pseudomonas aeruginosa) as compared to the cefixime and norfloxacin. This implies that the nanoparticles have the potential to be used in nano-medicine applications, such as drug delivery systems, as well as for their antibacterial, antifungal, and antiviral activities. Additionally, the development and application of materials and technologies at the nanometer scale opens possibilities for the creation of novel drugs and therapies. Overall, the study highlights the promising potential of herbal medicinal plants found in Murree, Punjab, Pakistan, and green-synthesized silver nanoparticles in various fields of medicine and nanotechnology.
Keywords: Green synthesis, Silver nanoparticles, Swertia chirata, Antimicrobial activity, Nanotechnology
1. Introduction
Anti-microbial resistance (AMR) is a growing global health concern due to the development of drug-resistant bacteria due to the widespread use of antibiotics [1]. This has resulted in an urgent need for the development of new and effective antimicrobial agents. Medicinal plants have long been used in traditional medicine to treat various ailments, including bacterial infections [2]. Numerous studies have reported the antibacterial activity of plant extracts against a wide range of bacteria [3]. These plant-based antimicrobial agents offer several advantages over synthetic antibiotics, including a lower toxicity profile, fewer side effects, and a diverse range of bioactive compounds that can target different aspects of bacterial growth and survival, making it difficult for bacteria to develop resistance [4].
Plant extracts are known to contain various bioactive compounds, such as alkaloids, flavonoids, tannins, and phenolic compounds [5], which have been shown to possess antimicrobial activity. However, the efficacy of plant-based antibiotics is limited due to factors such as poor solubility, bioavailability, and stability [6]. To address these limitations, researchers have turned to the use of nanoparticles, which possess unique physical and chemical properties that make them promising candidates for antimicrobial applications [7]. Silver nanoparticles, in particular, have been extensively studied for their broad-spectrum antimicrobial activity against both gram-positive and gram-negative bacteria [8].
Swertia chirata is a species of the Gentianaceae family. Roxburgh specified Gentiana chyrayta for the first time in 1814. Swertia chirata is a critically endangered medicinal plant that grows at high elevations in the sub-temperate Himalayas between 1200 and 2100 m heights from Kashmir to Bhutan [9,10]. The extensive list of medical applications includes the treatment of melancholia, chronic fever, hypertension, malaria, scanty urine, anemia, ulcers, bronchial asthma, epilepsy, hepatotoxic disorders, hepatitis, worms, gastritis, skin diseases, dyspepsia, constipation, and some types of mental disorders, as well as diabetes, blood purification, secretion of bile [11,12]. Swertia chirata extracts recently demonstrated anti-hepatitis B virus (anti-HBV) properties [13,14]. Decoctions of this species have historically been used as cardio protectants, anthelmintics, hepatoprotectives, hypoglycemics, antimalarials, antifungals, antibacterials, cardiostimulants, antifatigue, anti-inflammatory, antiaging, and antidiarrheal [12,15,16]. It also helps to reduce blood pressure and sugar levels [17]. Swertia chirata extract is found in various amounts in herbal preparations such as Ayush-64, Diabecon, Mensturyl syrup, and Melicon V ointment [18]. Traditional Chinese Medicine (TCM) significantly reduced the SARS-Cov-2 infection in China during the start of the pandemic. Swertia chirata was the key plant extract in all the TCMs utilized against COVID-19 [[19], [20], [21], [22]].
Several studies have investigated the antibacterial activity of Swertia chirata extracts against various bacterial strains, including Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa [23]. However, there is limited information on the antibacterial activity of silver nanoparticles synthesized from Swertia chirata harvested from the forests of Murree, Punjab, Pakistan. Therefore, this study aims to ascertain if Swertia chirata plant extracts and silver nanoparticles produced in various solvents have any antibacterial effects on gram-positive and gram-negative bacteria. The findings of this study could provide insights into the potential use of plant-based antibiotics and nanoparticles for the treatment of bacterial infections.
2. Materials and methods
2.1. Collection of plant material
The Swertia chirata plant was for the first time identified and collected from the forest of Murree, Punjab, Pakistan [Fig. 1(A and B)]. This study was conducted at the Microbiology lab, Department of Microbiology, Kohsar University Murree.
Fig. 1.
Map representing the site from where the samples of Swertia chirata were collected. (A) Map of Pakistan, (B) location of Murree.
2.2. Processing of sample
To prepare the plant sample for analysis, the leaves and stems were isolated and rinsed with sterile distilled water to eliminate any debris or unwanted substances. Once cleaned, the leaves and stems were dried in the dry air oven at 60 °C for 4 h and finely ground into powder form [24]. The resulting powder was then securely kept in a sterile container for further analysis.
2.3. Preparation of plant extracts
To extract compounds from the powdered samples, the stem, and leaves were subjected to extraction using methanol, ethanol, chloroform, and distilled water in a soxhlet apparatus at 60 °C for 48 h. After extraction, the resulting extracts were allowed to cool at room temperature and filtered using Whatman No.1 filter paper and then evaporated to complete dryness using a flash evaporator [Fig. 2(A–C)]. The dried extracts were scraped and stored in a clean and sterile container for further use [25].
Fig. 2.
Preparation and filtration of different extracts of Swertia chirata. A: Swertia chirata plant. B: Various extracts of Swertia chirata including ethanolic, methanolic, and chloroform extracts. C: Filtration of different extracts of Swertia chirata.
2.4. Phytochemical analysis
The qualitative phytochemical tests were conducted to detect the presence of different secondary metabolites.
2.5. Antioxidant activity
Antioxidant content was determined by using DPPH assay [26]. 1 mg of plant extract was mixed in 1 mL of DMSO to prepare the sample solution. From the above stock solution, a further 3 dilutions were made ranging from 25 to 100 μL. Then 50 μl of the sample solution was taken in the Eppendorf and mixed with 950 μl of methanol DPPH (0.004 %) was added in an Eppendorf tube to make the final volume of 1000 μl. Ascorbic acid was used as the positive control and DMSO as the negative control. Then the reaction mixture was kept in the incubator for 30 min in the dark at a room temperature of 25 °C. After that, the change in color of the mixture was observed. The appearance of yellow color indicates the presence of plant oxidation potential. The absorbance of the sample was measured by using a spectrophotometer at the wavelength of 517 nm.
2.6. Calculations
(A control - A sample) x 100/A control A = Absorbance.
2.7. Synthesis of silver nanoparticles
To synthesize silver nanoparticles (AgNPs) in an environmentally friendly manner, the Swertia chirata plant extracts were introduced into a solution of silver nitrate (AgNO3) and stirred continuously while maintaining an ambient temperature of 15 °C–25 °C [27]. The synthesis of AgNPs was observed at different intervals of time, with varying concentrations of both silver nitrate (AgNO3) and plant extracts being used in the process (Fig. 3).
Fig. 3.
Siver Nanoparticles Synthesis from various extracts of Swertia chirata.
2.8. Characterization of synthesized silver nanoparticles
To investigate the bio-reductive properties of Swertia chirata leaf extracts and their ability to form AgNPs, a BioBase BK-D590 double-beam UV–visible spectrophotometer with a wavelength range of 190 nm–1100 nm was employed [28]. Optical density (OD) measurements were recorded to confirm the reduction of silver nitrate during the process.
The elemental analysis of the green synthesized nanoparticles was performed with an EDX (model: OXFORD_INCA PENTx3) and recorded with an electronic microscope (model: JEOL JSM 5410).
The morphological characteristics of biosynthesized silver nanoparticles produced from plant extract have been studied using SEM. After adding AgNO3 for 48 h, the solutions were spread out on slides to create the SEM samples. To make the samples conductible, a thin coating of platinum was applied to them. Following that, the samples were characterized in the SEM using a 20 kV accelerating voltage.
2.9. Test microorganisms
The common human pathogenic strains such as Escherichia coli, S. capitis, Pseudomonas aeruginosa, and B. subtilis were obtained from the Department of Microbiology, Kohsar University Murree.
2.10. Assessment of antimicrobial activity of plant extracts and silver nanoparticles
To determine the antimicrobial effectiveness of silver nanoparticles and the plant extracts of Swertia chirata against bacterial strains such as Escherichia coli, and S. capitis. Pseudomonas aeruginosa and B. subtilis, the well-diffusion method was utilized [29]. Overnight cultures of each pathogenic strain were taken and 100 μl of bacteria were evenly spread on Muller Hinton Agar plates using a sterile glass spreader. Gel puncture was used to make 6 mm wells on the agar plates, and different concentrations (25, 50, and 100 μl) of silver nanoparticle and ethanolic, methanolic, chloroform, and aqueous extracts of the plant were poured into each well using a micropipette. The study aimed to investigate the antimicrobial activity of Swertia chirata plant extracts and silver nanoparticles prepared in four different solvents, namely ethanol, methanol, chloroform, and distilled water, against four pathogenic bacteria, Escherichia coli, S. capitis, Pseudomonas aeruginosa, and B. subtilis. Antibiotic discs such as cefixime and norfloxacin were used as positive controls. The plates were incubated at 37 °C for 24 h in an incubator for further growth. Following inoculation, the diameter of the zone of inhibition around each well was measured.
3. Results and discussion
3.1. Qualitative phytochemical analysis
Swertia chirata has great importance in traditional medicine as well as folk medicine, for the treatment of several diseases. The plant has several bioactive secondary metabolites that are good sources of medicines for curing numerous microbial diseases and improving the condition of human health [14,17]. At present, several researchers have led their attention to exploring various phytochemical constituents from this plant. The presence of a diversified group of pharmacologically bioactive chemicals belonging to several groups, such as xanthones and their derivatives, secoiridoids, lignans, iridoids, alkaloids, terpenoids, and flavonoids, are credited to Swertia chirata's broad range of biological activities [14,30]. Other components include chitin, ophelic acid, palmitic acid, oleic acid, and stearic acid. Chiratanin, which is found in several parts of Swertia chirata, was the first dimeric xanthone to be isolated [31].
In the current study, the phytochemical analysis of Swertia chirata collected from the Murree Forest, Punjab was carried out on different extracts (ethanolic, methanolic, chloroform, and distilled water). In phytochemical analysis, qualitative and quantitative tests were performed. Qualitative tests were performed to know the presence or absence of the different compounds in these plant extracts. The extracts of Swertia chirata showed positive results for several phytochemicals. Ethanolic extract of Swertia chirata contained all the phytochemicals including phenols, flavonoids, alkaloids, terpenoids, tannins, saponins, glycosides, steroids, phytosterol, xanthones, coumarins, carbohydrates, anthocyanin, quinine, and lignin. Chloroform extract lacked phenols and coumarins while methanolic extract showed negative results for saponins and lignin (Table 1). Similar metabolites were also isolated from the Swertia chirata plant growing in Nepal [32,33], India [34], Pakistan [35], and China [13].
Table 1.
Qualitative phytochemical analysis of different extracts of Swertia chirata.
| Phytochemicals | Distilled water extract | Methanolic extract | Ethanolic extract | Chloroform extract |
|---|---|---|---|---|
| Phenols | + | + | ++ | – |
| Flavonoids | + | ++ | + | ++ |
| Alkaloids | + | + | +++ | + |
| Terpenoids | ++ | ++ | + | ++ |
| Saponins | + | – | ++ | + |
| Tannins | + | + | ++ | +++ |
| Glycosides | – | +++ | + | ++ |
| Steroid | + | + | + | + |
| Phytosterol | – | ++ | +++ | ++ |
| Xanthones | ++ | ++ | + | + |
| Coumarins | – | + | + | – |
| Carbohydrates | ++ | + | +++ | ++ |
| Anthocyanin | – | +++ | ++ | +++ |
| Quinone | + | ++ | ++ | + |
| Lignin | + | – | + | ++ |
3.2. Quantitative phytochemical analysis
Quantitative phytochemical analysis of a different extract of the plant was performed. In which the total phenolic content was expressed by using the standard curve equation (Y = 0.0038x+0.034), the slop was generated for x which is for Gallic Acid concentration 0.0038 and 0.0346 for the intersection. Total flavonoid content (TFC) was evaluated by using standard curve EQ(Y = 0.0038x+0.034), the slop was generated for x which is the quercetin concentration 0.0038, and 0.0346 is for the intersection. Numerous plants contain flavonoids, which are thought to decrease the cyclooxygenase enzyme's activity and have antibacterial and antiparasitic properties [36,37]. The results revealed that maximum TPC (197.64 ± 1.00 Gallic Acid Eq.mg/g) and TFC (149.58 ± 0.15 Quercetin Eq.mg/g) were recorded in methanolic extract of Swertia chirata, followed by ethanolic extract. Whereas the lowest TPC and TFC were expressed by aqueous extract (Table 2). In a previous study, the methanolic extract of the Swertia chirata plant collected from Nepal contained 26.16 ± 0.25 mg QE/g of TFC and 67.49 ± 0.50 GAE/g of TPC [38]. In the ethanol extract of Swertia chirata, Chen et al. [39] calculated the total flavonoid content to be 4.98 ± 0.40 mg rutin equivalents/g, and Tripathi et al. [40] found 10.6 μg equivalents of quercetin in 50 g of aqueous extract of Swertia chirata. Furthermore, differences in plant collection time and site may affect the concentrations of flavonoid and phenolic content [41].
Table 2.
Qualitative phytochemical analysis of different extracts of Swertia chirata.
| Extract | TPC(Gallic Acid Eq.mg/g) | TFC (Quercetin Eq.mg/g) |
|---|---|---|
| Ethanolic extract | 192.64 ± 0.15 | 144.28 ± 0.40 |
| Methanolic extract | 197.64 ± 1.00 | 149.58 ± 0.15 |
| Chloroform extract | 155.71 ± 1.67 | 147.36 ± 0.95 |
| Aqueous extract | 147.56 ± 0.15 | 139.29 ± 0.80 |
3.3. Antioxidant potential of various extracts of Swertia chirata
Antioxidants play an important role in protecting against damage by reactive oxygen species. Antioxidants are biologically active phytochemicals that are naturally found in various fruits, vegetables, grains, and herbs which perform a protective function as an effective defense against oxidative damage from oxidizing agents and free radicals [37]. Cells have evolved a variety of defense systems based on both water-soluble and lipid-soluble antioxidants and antioxidant enzymes. A major proportion of antioxidant systems of the human body are dependent on dietary constituents. Antioxidants from plant extract are compounds that demonstrate biological activity that can protect the body from damage caused by free radical-induced oxidative stress [42,43].
The stable free radical DPPH may take an electron or a hydrogen atom to transform into a stable diamagnetic radical, which is then scavenged by a substrate that can donate protons. According to reports, the phenolic compounds can scavenge DPPH radicals which causes their absorbance to reduce [36,44]. This discoloration from purple to yellow is the consequence of the interplay between antioxidant molecules and radicals.
All the extracts demonstrated concentration-dependent radical scavenging activity. The percent DPPH antioxidant activity increased with the increase in the concentration of extracts. At higher concentrations, all the extracts showed significant levels of antioxidant activity. The maximum antioxidant activity was recorded with 100 μl of methanolic extract (98 ± 7.3%), followed by ethanolic extract (90.2 ± 4.6%) at similar concentrations. The lowest percentage of antioxidant activity was shown by the aqueous extract (37.7 ± 2.4%) of Swertia chirata at 25 μl concentration (Fig. 4). Previously, 100 μg/mL of methanolic extract of Swertia chirata collected from the Galyat region of Khyber Pakhtunkhwa, Pakistan had shown 85.77 ± 2.49% antioxidant potential [41]. Sharma et al. [45] assessed the antioxidant activity of the Swertia chirata extract (collected from India) by measuring its free radical scavenging ability (DPPH test). The antioxidant activity of acetonic and methanolic plant extracts was investigated using butylated hydroxytoluene. The EC50 value of methanolic extract was determined to be 27.70 μg/mL, which was equivalent to the EC50 value of butylated hydroxytoluene extract (17.75 μg/mL). This demonstrates unequivocally that the methanolic extract of Swertia chirata has strong antioxidant properties. Similarly, Chen et al. [46] used antioxidant assays such as the reducing power and beta-carotene assay to examine the antioxidant properties of the 70% ethanolic extract of Swertia chirata. According to the findings, extracts made from 70% ethanol had a significant level of DPPH scavenging activity (IC50 = 267.80 μg/mL).
Fig. 4.
DPPH Antioxidant potential of different extracts of Swertia chirata.
3.4. Biosynthesis and characterization of silver nanoparticles
In the current study, Swertia chirata plant extracts were used to biosynthesize silver nanoparticles. The Silver ions were converted to NPs with the presence of plant extract. A stabilizing and capping agent was provided as a plant extract. Numerous investigations have found that plant extract contains active substances that lead to the synthesis of AgNPs [44,47,48]. Furthermore, the environmentally friendly and toxin-free production of NPs utilizing plant component extract is of paramount relevance [48].
SEM, EDX, and UV–visible spectroscopy were employed to analyze the newly phytosynthesized AgNPs. Combinations of techniques are often required for NP characterization since a single methodology is inadequate to accurately describe the colloidal NPs. Several characterizing peaks are seen for the synthesis of AgNPs, mainly in the range of 410–480 nm [[49], [50], [51], [52]]. However, colloidal AgNPs may have varied sizes and morphologies at different wavelengths.
It was reported previously that the SPR peak of silver nanoparticles synthesized using Swertia chirata was detected at 450 nm [53]. In the present study, silver nanoparticles were characterized using a double-beam photo spectrometer ranging in wavelength from 400 nm to 600 nm. The highest OD value was observed at the wavelengths of 400 nm and 420 nm (0.390 and 0.440, respectively). Color changes of silver nanoparticles were observed at different wavelengths from dark brown to red. A characterization peak for the AgNPs made from Swertia chirata can be seen in Fig. 5.
Fig. 5.
UV–Vis spectra of photosynthesized silver nanoparticles using extract of Swertia chirata.
The structural characteristics of the produced AgNPs were examined using SEM. According to SEM examination, the newly photosynthesized nanoparticles were round and cuboidal in form, with a diameter ranging from 80 to 110 nm (Fig. 6). Similar SEM results were also reported in a previous study where aqueous extract of Swertia chirata (from India) was used to synthesize silver nanoparticles [53].
Fig. 6.
SEM of silver nanoparticles green synthesizing through Swertia chirata.
EDX was used to conduct an elemental analysis of the produced AgNPs. Using an EDX detector, silver ions were confirmed to be present. The most prominent silver peak was visible in the 2.5–3.5 keV range of the EX-spectrum (Fig. 7). The silver atoms in the nanoparticles produce significant signals at 3 keV, a peak that is typical of metallic silver nanocrystals. The findings were consistent with other studies of silver nanoparticle EDX spectra [[54], [55], [56]].
Fig. 7.
EDX spectrum of photosynthesized silver nanoparticles through Swertia chirata.
3.5. Antimicrobial susceptibility test
The problem of drug resistance in bacterial infections is a major challenge in modern medicine [57]. Antibiotic overuse and misuse have led to the emergence of drug-resistant strains, making traditional antibiotics less effective [[58], [59], [60]]. Therefore, there is a growing interest in the development of alternative treatments, such as plant-based antimicrobials [61]. This study investigated the antimicrobial activity of Swertia chirata plant extracts and silver nanoparticles against human pathogenic bacteria, including Escherichia coli, S. capitis, Pseudomonas aeruginosa, and B. subtilis. These pathogenic microorganisms not only cause disease in humans but also food-borne pathogens and play a vital role in food spoilage [62].
In the antimicrobial susceptibility test, the zones of inhibition were recorded in mm diameter. The plant extract prepared in all four solvents and their silver nanoparticles and norfloxacin antibiotic discs showed significant antibacterial activity against the pathogenic microbes (Table 3, Fig. 8). The zone of bacterial growth inhibition increased with the increase in concentration of extracts and nanoparticles. The results showed that Swertia chirata plant extracts and silver nanoparticles had significant antimicrobial activity against Escherichia coli, S. capitis, B. subtilis, and Pseudomonas aeruginosa. However, the antibiotics applied to the microbes showed limited antibacterial activity, indicating that these bacteria are resistant to antibiotics. In the current study, significant antibacterial activity was detected against E.coli (30.7 ± 2.63 mm), followed by S. capitas (29.3 ± 1.69 mm) and Pseudomonas aeruginosa (28.8 ± 1.37 mm) when exposed to higher concentration (100 μl) of methanolic extract of Swertia chirata or AgNps synthesized from the same extract. A moderate level of antibacterial activity was also exhibited by the ethanolic, chloroform, and aqueous extracts of Swertia chirata. A previous study conducted in India reported that AgNPs synthesized from methanolic extract of Swertia chirata leaves exhibited significant antibacterial activity against Escherichia coli and Klebsiella pneumonia [63].
Table 3.
Antibacterial activity of plant extracts, silver nanoparticles, and antibiotics against E.coli, S. capital, Pseudomonas aeruginosa, and B. subtilis (Zone of inhibition is recorded as mm).
| Extracts | E. coli | S. capital | P. aeruginosa | B. subtilis |
|---|---|---|---|---|
| 25 μl concentration | ||||
| Ethanolic extract | 5.1 ± 0.18 | 7.3 ± 1.02 | 7.9 ± 1.17 | 2.4 ± 0.82 |
| Ethanolic nanoparticles | 7.9 ± 0.24 | 8.8 ± 0.61 | 9.3 ± 1.07 | 5.1 ± 0.21 |
| Methanolic extracts | 6.2 ± 0.21 | 4.7 ± 0.21 | 6.9 ± 0.63 | 1.3 ± 0.11 |
| Methanolic extracts nanoparticles | 10.7 ± 0.46 | 12.8 ± 0.91 | 9.6 ± 0.69 | 6.6 ± 1.08 |
| Chloroform extract | 8.7 ± 0.17 | 7.7 ± 0.58 | 6.3 ± 0.46 | 1.9 ± 0.79 |
| Chloroform nanoparticles | 10.6 ± 0.82 | 10.3 ± 0.52 | 7.6 ± 0.85 | 3.9 ± 0.61 |
| Aqueous extracts | 4.1 ± 0.43 | 6.2 ± 0.73 | 4.9 ± 0.31 | 2.7 ± 0.43 |
| Aqueous nanoparticles | 7.2 ± 0.69 | 7.9 ± 0.48 | 5.1 ± 0.42 | 4.4 ± 0.77 |
| Cefixime antibiotic | 1.21 ± 0.08 | 4.8 ± 0.66 | 3.3 ± 0.29 | 0 ± 0.00 |
| Norfloxacin antibiotic | 6.3 ± 0.12 | 5.5 ± 0.39 | 4.1 ± 0.30 | 0.3 ± 0.02 |
| 50 μl concentration | ||||
| Ethanolic extract | 6.9 ± 0.88 | 9.6 ± 1.22 | 8.5 ± 0.97 | 4.3 ± 0.62 |
| Ethanolic nanoparticles | 10.2 ± 1.05 | 11.7 ± 0.98 | 10.6 ± 0.77 | 5.6 ± 0.44 |
| Methanolic extracts | 7.9 ± 0.48 | 7.6 ± 0.77 | 8.3 ± 1.19 | 3.3 ± 0.27 |
| Methanolic extracts nanoparticles | 12.6 ± 0.63 | 14.1 ± 1.55 | 11.2 ± 1.91 | 7.7 ± 0.88 |
| Chloroform extract | 9.4 ± 1.02 | 8.2 ± 0.76 | 8.1 ± 0.67 | 5.7 ± 0.82 |
| Chloroform nanoparticles | 13.1 ± 1.25 | 12.9 ± 0.91 | 8.9 ± 0.54 | 7.0 ± 0.48 |
| Aqueous extracts | 6.4 ± 1.03 | 7.9 ± 1.62 | 6.6 ± 0.53 | 4.1 ± 0.63 |
| Aqueous nanoparticles | 8.9 ± 0.88 | 10.4 ± 1.19 | 9.2 ± 1.12 | 4.4 ± 0.68 |
| Cefixime antibiotic | 3.7 ± 0.61 | 5.8 ± 0.73 | 4.7 ± 0.59 | 0.7 ± 0.08 |
| Norfloxacin antibiotic | 8.4 ± 0.89 | 7.5 ± 0.92 | 5.8 ± 0.49 | 1.5 ± 0.16 |
| 100 μl concentration | ||||
| Ethanolic extract | 18.3 ± 1.71 | 18.2 ± 0.23 | 16.9 ± 0.63 | 4.4 ± 0.46 |
| Ethanolic nanoparticles | 25.9 ± 1.04 | 24.8 ± 0.63 | 22.6 ± 1.09 | 12.3 ± 0.79 |
| Methanolic extracts | 25.1 ± 0.98 | 29.3 ± 1.69 | 21.0 ± 1.77 | 6.4 ± 1.30 |
| Methanolic extracts nanoparticles | 30.7 ± 2.63 | 28.7 ± 2.01 | 28.8 ± 1.37 | 14.9 ± 1.21 |
| Chloroform extract | 24.0 ± 0.77 | 21.3 ± 0.48 | 21.3 ± 0.66 | 5.3 ± 0.79 |
| Chloroform nanoparticles | 26.7 ± 0.91 | 24.1 ± 0.61 | 20.1 ± 1.15 | 9.1 ± 1.21 |
| Aqueous extracts | 22.1 ± 0.83 | 17.2 ± 1.31 | 17.9 ± 0.61 | 4.1 ± 0.36 |
| Aqueous nanoparticles | 27.2 ± 1.29 | 26.5 ± 0.78 | 22.1 ± 0.88 | 6.7 ± 0.48 |
| Cefixime antibiotic | 5.2 ± 0.44 | 8.8 ± 0.56 | 11.3 ± 0.29 | 1.9 ± 0.14 |
| Norfloxacin antibiotic | 21.3 ± 0.78 | 19.3 ± 0.89 | 23.7 ± 1.10 | 4.2 ± 0.42 |
Fig. 8.
Antibacterial activity of different plant extracts, nanoparticles, and antibiotics against various bacteria.
According to Ahluwalia et al. [64], 20 μg/mL AgNPs synthesized from an aqueous extract of Swertia paniculata showed significant antibacterial activity against P. aeuriginosa with a zone of inhibition of 18.80 ± 0.72 mm, while Staphylococcus aureus exhibited the zone of inhibition of 14.67 ± 0.35 mm using. It was also observed that gram-negative bacterial strains, such as Pseudomonas aeruginosa and Klebsiella pneumonia were more susceptible to AgNPs than Staphylococcus aureus [64]. Similar results were also observed in the current study, B. subtilis showed remarkable resistance against AgNPs and plant extracts as compared to other microbes. No zone of inhibition was formed when B. subtilis was treated with cefixime at a lower concentration (25 μl) (Table 3).
The higher antimicrobial activity of ethanolic and methanolic extracts and silver nanoparticles can be attributed to the presence of phytochemicals such as alkaloids, flavonoids, and tannins, which are known for their antibacterial activity [65]. Gram-positive bacteria have thick peptidoglycan layers in their cell walls, whereas gram-negative bacteria have thin peptidoglycan layers. The degree of bioactivity is significantly influenced by how permeable a chemical is to the peptidoglycan layer [66,67]. Due to the compositional differences between the cell walls of Gram-positive and Gram-negative bacteria, several antimicrobial agents exhibit varying behaviors [68]. Numerous researchers have put up various hypotheses.
According to Sondi et al. [69], the interaction between the silver cations generated by NPs and the bacterial cell wall enhanced the permeability of the cell membrane, which would explain the significant bactericidal activity. The attachment of silver NPs or ions to the cell wall results in a concentration of envelop protein precursors, which denaturizes the protein [70]. According to literature studies, when silver ions interact with the thiol groups of enzymes, Reactive Oxygen Species (ROS) are produced, which causes the cell wall to self-destruct [71]. According to Morones et al. [72], silver works as a mild acid, causing the DNA to be damaged along with its nuclear machinery. The increased activity of the AgNPs may be attributed to their nanosize and phytochemical capping. Due to their nano size, silver nanoparticles may have a greater penetration rate in cell walls, and phytochemicals can improve their biological activities [73]. Dihydrofolate reductase (DHFR), an essential cofactor involved in the production of amino acids, may be bound by phytochemicals [74].
In conclusion, the findings of this study suggest that Swertia chirata plant extracts and silver nanoparticles can be used as potential antibacterial agents against pathogenic bacteria. However, further studies are needed to investigate the mechanism of action and toxicity of these extracts and nanoparticles before they can be considered for clinical use.
4. Conclusion
In the current study, phytochemical analysis of the medicinal plant collected for the first time from the forests of Murree, Punjab, Pakistan (Swertia chirata) revealed that it contains several phytochemicals with significant antioxidant potential. The current work also illustrated a green and environmentally acceptable nano-synthetic mechanism for the photoproduction of durable and spherical nanosilver particles. During the photo-manufacturing of silver nanoparticles (AgNPs) from silver nitrate, different extracts of the medicinal plant Swertia chirata (aqueous, ethanolic, methanolic, and chloroform extracts) were used as a capping and reducing agent. The findings of physical-chemical characterization showed that the produced AgNPs had a spherical form and the optimal size range. Furthermore, the result of antibacterial analysis suggests that the methanolic and ethanolic extracts and silver nanoparticles could be used as natural alternatives to synthetic antibiotics for the treatment of bacterial infections, particularly against E. coli, P. aeruginosa, B. subtilis, and S. capitis. Overall, this environmentally friendly technology may be a competitive alternative to existing physical or chemical processes for the production of nanoparticles and may be employed as inhibitors in a range of biological applications. Further studies are needed to identify the active compounds responsible for the antimicrobial activity and to evaluate the toxicity of the plant extracts and silver nanoparticles.
Data availability statment
No data was used for the research described in the article.
CRediT authorship contribution statement
Muhammad Adnan Shereen: Methodology, Investigation, Formal analysis. Aftab Ahmad: Formal analysis, Data curation. Hashir Khan: Methodology, Investigation, Formal analysis, Data curation. Sadia Mehmood Satti: Visualization, Formal analysis, Data curation, Conceptualization. Abeer Kazmi: Writing – original draft, Supervision, Conceptualization. Nadia Bashir: Writing – review & editing, Writing – original draft, Formal analysis, Data curation. Muhammad Shehroz: Software, Resources, Methodology, Formal analysis. Shahid Hussain: Writing – original draft, Software, Resources, Methodology, Investigation, Formal analysis, Data curation. Muhammad Ilyas: Software, Resources, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. M. Ijaz Khan: Writing – original draft, Supervision, Project administration, Investigation, Data curation, Conceptualization. Hatoon A. Niyazi: Writing – review & editing, Visualization, Validation, Supervision, Project administration, Investigation, Funding acquisition, Formal analysis, Conceptualization. Ferjeni Zouidi: Writing – review & editing, Visualization, Validation, Supervision, Resources, Project administration, Investigation, Funding acquisition, Formal analysis, Data curation, Conceptualization.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this research work through the Large Group Research Project under grant number RGP2/83/44.
Contributor Information
Muhammad Adnan Shereen, Email: adnan.shereen@kum.edu.pk.
Aftab Ahmad, Email: aftabahmad@kum.edu.pk.
Hashir Khan, Email: hashirkhanhashir52@gmail.com.
Sadia Mehmood Satti, Email: sadiasatti@kum.edu.pk.
Abeer Kazmi, Email: Abeer_kazmi@yahoo.com.
Nadia Bashir, Email: aadishereen@gmail.com.
Muhammad Shehroz, Email: muhammadshehroz@kum.edu.pk.
Shahid Hussain, Email: iiuibiotech@gmail.com.
Muhammad Ilyas, Email: dr.milyas@kum.edu.pk.
M. Ijaz Khan, Email: scientificresearchglobe@gmail.com.
Hatoon A. Niyazi, Email: hniyazi@kau.edu.sa.
Ferjeni Zouidi, Email: salhabed@kku.edu.sa.
References
- 1.Ferri M., Ranucci E., Romagnoli P., Vjcrifs Giaccone. nutrition. Antimicrobial resistance: A global emerging threat to public health systems. 2017;57(13):2857–2876. doi: 10.1080/10408398.2015.1077192. [DOI] [PubMed] [Google Scholar]
- 2.Ullah R., Alqahtani A.S., Noman O.M., Alqahtani A.M., Ibenmoussa S., Mjsjobs Bourhia. A review of ethno-medicinal plants used in traditional medicine in the Kingdom of Saudi Arabia. 2020;27(10):2706–2718. doi: 10.1016/j.sjbs.2020.06.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Egamberdieva D., Jabborova D., Babich S., Xalmirzaeva S., Salakhiddinov K., Madazimov M.J.E.S. Antimicrobial activities of herbal plants from Uzbekistan against human pathogenic microbes. 2021;4:87–94. [Google Scholar]
- 4.Ahmed I., MjjoM Mikail, Experimentation Paradigm shift: focusing on plant-based natural antimicrobials. 2017;5(2) [Google Scholar]
- 5.Chandrasekara A., Fjjot Shahidi, medicine c. Herbal beverages: bioactive compounds and their role in disease risk reduction-A review. 2018;8(4):451–458. doi: 10.1016/j.jtcme.2017.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Mohammadi K., Sani M.A., Azizi-Lalabadi M., Djjaic McClements, science i. 2022. Recent Progress in the Application of Plant-Based Colloidal Drug Delivery Systems in the Pharmaceutical Sciences. [DOI] [PubMed] [Google Scholar]
- 7.Fatima F., Siddiqui S., Khan W.A.J.B.T.E.R. Nanoparticles as novel emerging therapeutic antibacterial agents in the antibiotics-resistant era. 2021;199:2552–2564. doi: 10.1007/s12011-020-02394-3. [DOI] [PubMed] [Google Scholar]
- 8.Zhang J., Gao M., Gao W., Yang P., Meng F., Liu Q., et al. Functional Silver nanoparticles as broad-spectrum antimicrobial agents. 2022;46(34):16387–16393. [Google Scholar]
- 9.Mazumder M.A.R., Jubayer M.F., Ansari M.J., Ranganathan T.V. Chirayata/Chiretta. Immunity Boosting Medicinal Plants of the Western Himalayas. Springer; 2023. Swertia chirayita (Roxb. Ex flem.) pp. 511–539. [Google Scholar]
- 10.Bajaj S., Singh V., Ali M. New triterpene compounds from Swertia chirata. Ancient Sci. Life. 2017;37(1):37. [Google Scholar]
- 11.Sharma R., Singh S., Sood H. 2018. To Study the Effect of Polychromatic Light Emitting Diodes on Micropropagated Shoots of Swertia Chirayita and Picrorhiza Kurroa. [Google Scholar]
- 12.Roy S. Chattogram Veterinary & Animal Sciences University; 2020. Phytochemical Screening and Antimicrobial Efficacy of Ocimum Sanctum (Tulsi) and Swertia Chirayita (Chirota) against Escherichia coli and Salmonella Spp. Isolated from Poultry and Their Molecular Study. [Google Scholar]
- 13.Li Q., Li H.-J., Xu T., Du H., Huan Gang C.-L., Fan G., et al. Natural medicines are used in the traditional Tibetan medical system for the treatment of liver diseases. Front. Pharmacol. 2018;9:29. doi: 10.3389/fphar.2018.00029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kumar V., Van Staden J. A review of Swertia chirayita (Gentianaceae) as a traditional medicinal plant. Front. Pharmacol. 2016;6:308. doi: 10.3389/fphar.2015.00308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Mehrotra N., Ojha S.K., Tandon S. Drug development for cardiovascular diseases from ayurvedic plants. Feature. 2007;1:89. [Google Scholar]
- 16.Pradhan B.K., Badola H.K. Local knowledge on the use of Swertia chirayita as traditional medicine: conservation challenges in Sikkim Himalaya, India. Ethnobot. Res. Appl. 2015;14:345–355. [Google Scholar]
- 17.Dey P., Singh J., Suluvoy J.K., Dilip K.J., Nayak J. Utilization of Swertia chirayita plant extracts for management of diabetes and associated disorders: present status, future prospects and limitations. Natural Products and Bioprospecting. 2020;10:431–443. doi: 10.1007/s13659-020-00277-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sharma Y.P., Bhardwaj C., Sharma R., Thakur P., Sharma R. A new RP-HPLC method for simultaneous determination of amaroswerin, amarogentin and andrographolide in a herbal drug “Chirayata”. J. Chromatogr. Sci. 2023;61(2):172–176. doi: 10.1093/chromsci/bmac018. [DOI] [PubMed] [Google Scholar]
- 19.Gyawali R., Paudel P.N., Basyal D., Setzer W.N., Lamichhane S., Paudel M.K., et al. A review on ayurvedic medicinal herbs as remedial perspective for COVID-19. Journal of Karnali Academy of Health Sciences. 2020;3 [Google Scholar]
- 20.Omokhua-Uyi A.G., Van Staden J. Natural product remedies for COVID-19: a focus on safety. South Afr. J. Bot. 2021;139:386–398. doi: 10.1016/j.sajb.2021.03.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Ahmad M., Rashid S., Ahmad T. Spike protein of SARS-COV-2 as a potential target for phytochemical constituents: a literature review. Journal of Shifa Tameer-e-Millat University. 2021;4(2):124–130. [Google Scholar]
- 22.Shereen M.A., Bashir N., Khan M.A., Kazmi A., Khan S., Zhen L., et al. Covid-19 management: traditional Chinese medicine vs. western medicinal antiviral drugs, a review and meta-analysis. Fresenius Environ. Bull. 2021;30(5):5537–5549. [Google Scholar]
- 23.Manjulika Y., Kumar K.D., Sanjukta C., Geeta W.J.I.J.P.P.R. 2016. Comparative Antibacterial Efficacy of Swertia Chirata and Colocasia Esculenta; pp. 2016–2019. 8(12) [Google Scholar]
- 24.Zambra C., Hernández D., Reyes H., Riveros N., Lemus-Mondaca R. Kageneckia oblonga leaves subjected to different drying methods: drying kinetics, energy consumption and interesting compounds. Front. Sustain. Food Syst. 2021;5 [Google Scholar]
- 25.Abubakar A.R., Haque M. Preparation of medicinal plants: basic extraction and fractionation procedures for experimental purposes. J. Pharm. BioAllied Sci. 2020;12(1):1. doi: 10.4103/jpbs.JPBS_175_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Braca A., Sortino C., Politi M., Morelli I., Mendez J. Antioxidant activity of flavonoids from Licania licaniaeflora. J. Ethnopharmacol. 2002;79(3):379–381. doi: 10.1016/s0378-8741(01)00413-5. [DOI] [PubMed] [Google Scholar]
- 27.Forough M., Farhadi K. Biological and green synthesis of silver nanoparticles. Turk. J. Eng. Environ. Sci. 2010;34(4):281–287. [Google Scholar]
- 28.Ijaz Hussain J., Kumar S., Adil Hashmi A., Khan Z. Silver nanoparticles: preparation, characterization, and kinetics. Adv. Mater. Lett. 2011;2(3):188–194. [Google Scholar]
- 29.Balouiri M., Sadiki M., Ibnsouda S.K. Methods for in vitro evaluating antimicrobial activity: a review. J. Pharm. anal. 2016;6(2):71–79. doi: 10.1016/j.jpha.2015.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Tovilovic-Kovacevic G., Zogovic N., Krstic-Milosevic D. Elsevier; 2020. Secondary Metabolites from Endangered Gentiana, Gentianella, Centaurium, and Swertia Species (Gentianaceae): Promising Natural Biotherapeutics. Biodiversity and Biomedicine; pp. 335–384. [Google Scholar]
- 31.Akbar S. Handbook of 200 Medicinal Plants: A Comprehensive Review of Their Traditional Medical Uses and Scientific Justifications. 2020. Swertia chirata buck.-ham. Ex wall. Swertia chirayita (Roxb.) H. Karsten (Gentianaceae) pp. 1699–1707. [Google Scholar]
- 32.Phoboo S., Pinto M.D.S., Bhowmik P.C., Jha P.K., Shetty K. Quantification of major phytochemicals of Swertia chirayita, a medicinal plant from Nepal. Ecoprint An Int. J. Ecol. 2010;17:59–68. [Google Scholar]
- 33.Subedi I., Karki T.B. Phytochemical and antimicrobial screening of native plant Swertia chirayita (Roxb. Ex fleming) karst from Rasuwa district of Nepal. J. Trop. Life Sc. 2018;8(2) [Google Scholar]
- 34.Yadav M., Chatterji S., Gupta S.K., Watal G. Preliminary phytochemical screening of six medicinal plants used in traditional medicine. Int. J. Pharm. Pharmaceut. Sci. 2014;6(5):539–542. [Google Scholar]
- 35.Mahmood S., Hussain S., Tabassum S., Malik F., Riaz H. Comparative phytochemical, hepatoprotective and antioxidant activities of various samples of Swertia Chirayita collected from various cities of Pakistan. Pak. J. Pharm. Sci. 2014;27(6):1975–1983. [PubMed] [Google Scholar]
- 36.Kazmi A., Khan M.A., Mohammad S., Ali A., Kamil A., Arif M., et al. Elicitation directed growth and production of steviol glycosides in the adventitious roots of Stevia rebaudiana Bertoni. Ind. Crop. Prod. 2019;139 [Google Scholar]
- 37.Kazmi A., Khan M.A., Huma A. Biotechnological approaches for production of bioactive secondary metabolites in Nigella sativa: an up-to-date review. International Journal of Secondary Metabolite. 2019;6(2):172–195. [Google Scholar]
- 38.Khanal S., Shakya N., Thapa K., Pant D.R. Phytochemical investigation of crude methanol extracts of different species of Swertia from Nepal. BMC Res. Notes. 2015;8(1):1–9. doi: 10.1186/s13104-015-1753-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Chen Y., Huang B., He J., Han L., Zhan Y., Wang Y. In vitro and in vivo antioxidant effects of the ethanolic extract of Swertia chirayita. J. Ethnopharmacol. 2011;136(2):309–315. doi: 10.1016/j.jep.2011.04.058. [DOI] [PubMed] [Google Scholar]
- 40.Tripathi R., Mohan H., Kamat J. Modulation of oxidative damage by natural products. Food Chem. 2007;100(1):81–90. [Google Scholar]
- 41.Khan M.A., Zia M., Arfan M., Nazir A., Fatima N., Naseer M., et al. Antioxidants, antimicrobial and cytotoxic potential of Swertia chirata. Biomed. Res. 2018;29(13):2722–2726. [Google Scholar]
- 42.Kazmi A., Khan M.A., Mohammad S., Ali A., Ali H. Biotechnological production of natural calorie free Steviol glycosides in stevia Rebaudiana: an update on current scenario. Curr. Biotechnol. 2019;8(2):70–84. [Google Scholar]
- 43.Shah S.K., Israr S.F., Khatak A.K., Kazmi A., Ali A., Mohammad S., et al. Quantitative analysis of fresh tomatoes (Solanum lycopersicum) for trace of pesticide residues from markets in Peshawar, Pakistan, using High Performance Thin Liquid Chromatography technique. Science and Technology Development Journal. 2020;23(3):708–714. [Google Scholar]
- 44.Anum F., Raja N.I., Sultana T., Kazmi A., Ali A., Qayyum B., et al. Spectral lights based treatment enhanced biomass accumulation and secondary metabolites production in callus culture of citrus reticulata. Philippine Agric. Sci. 2021;104(3) [Google Scholar]
- 45.Sharma N., Varshney V., Kala R.P., Bisht B., Sharma M. Antioxidant capacity and total phenolic content of Swertia chirayita (Roxb. ex Fleming) H. Karst. Int. J. Pharmaceut. Sci. Rev. Res. 2013;23(1):48. [Google Scholar]
- 46.Huang Chen Y.B., He J., Han L., Zhan Y., Wang Y. Vitro and in vivo antioxidant effects of the ethanolic extract of Swertia chirayita. J. Ethnopharmacol. 2011;136(2):309–315. doi: 10.1016/j.jep.2011.04.058. [DOI] [PubMed] [Google Scholar]
- 47.Ehsan M., Waheed A., Ullah A., Kazmi A., Ali A., Raja N.I., et al. BioMed research international; 2022. Plant-Based Bimetallic Silver-Zinc Oxide Nanoparticles: A Comprehensive Perspective of Synthesis, Biomedical Applications, and Future Trends; p. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ahmad I., Raja N.I., Kazmi A., Wahab A., Ali A., Younas Z., et al. Comprehensive approaches of nanoparticles for growth performance and health benefits in poultry: an update on the current scenario. BioMed Res. Int. 2022:2022. doi: 10.1155/2022/9539908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Anjum S., Abbasi B.H. Thidiazuron-enhanced biosynthesis and antimicrobial efficacy of silver nanoparticles via improving phytochemical reducing potential in callus culture of Linum usitatissimum L. Int. J. Nanomed. 2016:715–728. doi: 10.2147/IJN.S102359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Shireen F., Ahmad B., Ahmad L., Khan S.A., Rauf A., Khalil A.A., et al. Antineoplastic and cytotoxic evaluation of green AgNPs and crude extracts from agave americana, Mentha spicata, and Mangifera indica leaves. J. Nanomater. 2022:2022. [Google Scholar]
- 51.Hussain M., Raja N.I., Iqbal M., Aslam S. Applications of plant flavonoids in the green synthesis of colloidal silver nanoparticles and impacts on human health. Iran. J. Sci. Technol. Trans. A-Science. 2019;43:1381–1392. [Google Scholar]
- 52.Kingslin A., Kalimuthu K., Kiruthika M.L., Khalifa A.S., Nhat P.T., Brindhadevi K. Synthesis, characterization and biological potential of silver nanoparticles using Enteromorpha prolifera algal extract. Appl. Nanosci. 2023;13(3):2165–2178. [Google Scholar]
- 53.Kumar M., Sinha M.P. Green nanotechnology: synthesis of silver nanoparticles using aqueous leaf extract of Swertia chirayita. Nontlae Scientia Biologicae. 2017;9(3) [Google Scholar]
- 54.Lotfy W.A., Alkersh B.M., Sabry S.A., Ghozlan H.A. Biosynthesis of silver nanoparticles by Aspergillus terreus: characterization, optimization, and biological activities. Front. Bioeng. Biotechnol. 2021;9 doi: 10.3389/fbioe.2021.633468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Malathi G., Thillaiyadi V.C., Rizwana B.S., Vinayaka K., Udappusamy V., Nirmala P. Green synthesis of electrochemically active silver nanoparticles. Orient. J. Chem. 2023;39(1) [Google Scholar]
- 56.Wanjari A.K., Patil M.P., Chaudhari U.E., Gulhane V.N., Kim G.-D., Kiddane A.T. Bactericidal and photocatalytic degradation of methyl orange of silver-silver chloride nanoparticles synthesized using aqueous phyto-extract. Part. Sci. Technol. 2022;40(8):1033–1040. [Google Scholar]
- 57.Kurt Yilmaz N., Schiffer CAJCr. Introduction: drug resistance. 2021;121(6):3235–3237. doi: 10.1021/acs.chemrev.1c00118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Zhu Y., Hao W., Wang X., Ouyang J., Deng X., Yu H., et al. 2022. Antimicrobial Peptides, Conventional Antibiotics, and Their Synergistic Utility for the Treatment of Drug‐resistant Infections; pp. 1377–1422. 42(4) [DOI] [PubMed] [Google Scholar]
- 59.Saeed A., Yasmin A., Baig M., Khan K., Heyat M.B.B., Akhtar F., et al. Isolation and characterization of Lactobacillus crispatus, Lactococcus lactis, and Carnobacterium divergens as potential probiotic bacteria from fermented black and green olives (Olea europaea): an exploratory study. BioMed Res. Int. 2023:2023. doi: 10.1155/2023/8726320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Saeed A., Ali H., Yasmin A., Baig M., Ullah A., Kazmi A., et al. Unveiling the antibiotic susceptibility and antimicrobial potential of bacteria from human breast milk of Pakistani women: an exploratory study. BioMed Res. Int. 2023:2023. doi: 10.1155/2023/6399699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Chandra H., Bishnoi P., Yadav A., Patni B., Mishra A.P., Nautiyal A.R.J.P. Antimicrobial resistance and the alternative resources with special emphasis on plant-based antimicrobials—a review. 2017;6(2):16. doi: 10.3390/plants6020016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Hadi J., Wu S., Brightwell G. Antimicrobial blue light versus pathogenic bacteria: mechanism, application in the food industry, hurdle technologies and potential resistance. Foods. 2020;9(12):1895. doi: 10.3390/foods9121895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Deka DR, Das P, Paul DC, Sarma MP. Green Synthesis of Silver Nanoparticles Using Swertia Chirayita Leaves and its Effect against Selected Human Pathogens.
- 64.Ahluwalia V., Elumalai S., Kumar V., Kumar S., Sangwan R.S. Nano silver particle synthesis using Swertia paniculata herbal extract and its antimicrobial activity. Microb. Pathog. 2018;114:402–408. doi: 10.1016/j.micpath.2017.11.052. [DOI] [PubMed] [Google Scholar]
- 65.Alao, Oyekunle I.P., Iwuozor K.O., Emenike E.C. Green synthesis of copper nanoparticles and investigation of its anti-microbial properties. Advanced Journal of Chemistry-Section B. 2022;4(1):39–52. [Google Scholar]
- 66.Lohner K. Membrane-active antimicrobial peptides as template structures for novel antibiotic agents. Curr. Top. Med. Chem. 2017;17(5):508–519. [PubMed] [Google Scholar]
- 67.Lobiuc A., Pavăl N.-E., Mangalagiu, Gheorghiță R., Teliban G.-C., Amăriucăi-Mantu D., et al. Future antimicrobials: natural and functionalized phenolics. Molecules. 2023;28(3):1114. doi: 10.3390/molecules28031114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Mai-Prochnow A., Clauson M., Hong J., Murphy A.B. Gram positive and Gram negative bacteria differ in their sensitivity to cold plasma. Sci. Rep. 2016;6(1) doi: 10.1038/srep38610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Sondi I., Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 2004;275(1):177–182. doi: 10.1016/j.jcis.2004.02.012. [DOI] [PubMed] [Google Scholar]
- 70.Abdel-Hadi A., Iqbal D., Alharbi R., Jahan S., Darwish O., Alshehri B., et al. Myco-synthesis of silver nanoparticles and their bioactive role against pathogenic microbes. Biology. 2023;12(5):661. doi: 10.3390/biology12050661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Caiati C., Stanca A., Lepera M.E. Free radicals and obesity-related chronic inflammation contrasted by antioxidants: a new perspective in coronary artery disease. Metabolites. 2023;13(6):712. doi: 10.3390/metabo13060712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Morones J.R., Elechiguerra J.L., Camacho A., Holt K., Kouri J.B., Ramírez J.T., et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16(10):2346. doi: 10.1088/0957-4484/16/10/059. [DOI] [PubMed] [Google Scholar]
- 73.Amor I.B., Zeghoud S., Hemmami H. Biosynthesis of silver nanoparticles and their applications: short review. Algerian journal of Biosciences. 2023;4(1):52–63. [Google Scholar]
- 74.Gurushankar K., Rimac H., Nadezhda P., Grishina M. Exploring the potential and identifying Withania somnifera alkaloids as novel dihydrofolate reductase (DHFR) inhibitors by the AlteQ method. J. Biomol. Struct. Dyn. 2023:1–14. doi: 10.1080/07391102.2023.2175727. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No data was used for the research described in the article.








